Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51
United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Adrian Rawcliffe
12 Aug 2026
Director
Sold on a plan
12,700
$5.29
$67.18K
Aik Na Tan
11 Aug 2026
Director
Sold on a plan
432
$6.01
$2.60K
Ken Takanashi
11 Aug 2026
Director
Sold on a plan
3,864
$6.01
$23.22K
Mark Corrigan
8 Dec 2025
Director
Sold on a plan
6,515
$14.07
$91.63K
Mark Corrigan
8 Dec 2025
Director
Sold on a plan
9,600
$13.09
$125.66K
Gregory L. Verdine
8 Dec 2025
Director
Sold on a plan
7,980
$14.05
$112.12K
Gregory L. Verdine
8 Dec 2025
Director
Sold on a plan
12,020
$13.09
$157.34K
Adrian Rawcliffe
13 Nov 2025
Director
Sold on a plan
16,115
$6.79
$109.42K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 35
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 5,330,778
History held since 18 Nov 2015